Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | CCR5 | P51681 | 1/20 | 0.60 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | NFKBIA | P25963 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26130986 | 0.92 | CCR1 (0.60) | CCR1RAB9ACCR5METAP2MAPT | |
| SCHEMBL31191929 | 0.92 | CCR1 (0.60) | CCR1RAB9ACCR5METAP2MAPT | |
| SCHEMBL460366 | 0.83 | CCR1 (0.44) | CCR1RAB9ACCR5MAPTKMT2A | |
| SCHEMBL3225066 | 0.79 | CCR1 (0.58) | CCR1RAB9ACCR5METAP2MAPT | |
| SCHEMBL16690878 | 0.78 | CCR1 (0.62) | CCR1RAB9ACCR5METAP2MAPT | |
| Neocuproine SCHEMBL29367091 | 0.78 | CCR1 (1.00) | CCR1RAB9ACCR5METAP2MAPT | |
| Neocuproine SCHEMBL29639703 | 0.78 | CCR1 (1.00) | CCR1RAB9ACCR5METAP2MAPT | |
| Neocuproine SCHEMBL124563 | 0.78 | CCR1 (1.00) | CCR1RAB9ACCR5METAP2MAPT | |
| Neocuproine SCHEMBL11672280 | 0.78 | CCR1 (1.00) | CCR1RAB9ACCR5METAP2MAPT | |
| Broquinaldol SCHEMBL2110667 | 0.77 | MAPT (0.54) | CCR1RAB9ACCR5METAP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018211148-A1 | BISQUINOLIUM DERIVATIVES FOR PREVENTING OR TREATING EBV-RELATED CANCERS | UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) | 2018-11-22 | — | — | WO | disclosed |
| US-20080206890-A1 | BIS(2,9-DI-TERT-BUTYL-1,10-PHENANTHROLINE)COPPER(I) COMPLEXES, METHODS OF SYNTHESIS, AND USES THEROF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080206890-A1 | BIS(2,9-DI-TERT-BUTYL-1,10-PHENANTHROLINE)COPPER(I) COMPLEXES, METHODS OF SYNTHESIS, AND USES THEROF | TTI1, TTI2, TCOF1 | CCR1 2095/4885RAB9A 1064/4885CCR5 3407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.